Use of Faricimab in the real-world clinical practice for non-treatment naive neovascular age-related macular degeneration patients

被引：0
|
作者：
Tran, Donald [1 ]
Trung M. Dang [1 ]
Moodie, Jonathan [1 ]
Luckie, Alan [1 ]
机构：
[1] Eye Clin Albury Wodonga, Albury, NSW, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2023年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
下载
收藏
页码：1020 / 1020
页数：1
相关论文
共 50 条
  • [21] Short-term outcomes of intravitreal faricimab for treatment-naive neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hoshino, Junki
    Nakamura, Kosuke
    Nagashima, Tetsuhiro
    Akiyama, Hideo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (10) : 2945 - 2952
  • [22] Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
    Daien, Vincent
    Finger, Robert P.
    Talks, James S.
    Mitchell, Paul
    Wong, Tien Y.
    Sakamoto, Taiji
    Eldem, Bora M.
    Korobelnik, Jean-Francois
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (11) : 1475 - 1479
  • [23] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [24] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study-6 month results
    Khanani, Arshad M.
    Aziz, Aamir A.
    Khan, Hannah
    Gupta, Ashwin
    Mojumder, Ohidul
    Saulebayeva, Aigerim
    Abbey, Ashkan M.
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark R.
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara J.
    London, Nikolas J. S.
    Mein, Luke
    Sheth, Veeral S.
    Wolfe, Jeremy D.
    Singer, Michael A.
    Danzig, Carl J.
    EYE, 2023, 37 (17) : 3574 - 3581
  • [25] Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series
    Maria A. Bantounou
    Mohammed Elsheikh
    Adelehin Ijasan
    Cynthia Santiago
    BMC Ophthalmology, 25 (1)
  • [26] RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN A REAL WORLD CLINICAL SETTING
    Abell, Robin
    Lim, Diane
    Kerr, Nathan
    Allen, Penelope
    Vote, Brendan
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 103 - 104
  • [27] RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Results From LUMINOUS, a Global Real-World Study
    Holz, Frank G.
    Figueroa, Marta S.
    Bandello, Francesco
    Yang, Yit
    Ohji, Masahito
    Dai, Hong
    Wykrota, Halina
    Sharma, Sanjay
    Dunger-Baldauf, Cornelia
    Lacey, Sue
    Macfadden, Wayne
    Mitchell, Paul
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (09): : 1673 - 1685
  • [28] Managing Neovascular Age-Related Macular Degeneration Is More Research Needed to Improve Real-world Practice?
    Virgili, Gianni
    Parravano, Mariacristina
    Schmucker, Christine
    JAMA OPHTHALMOLOGY, 2016, 134 (05) : 553 - 554
  • [29] Recurrence of neovascular (wet) age-related macular degeneration (AMD) in patients discharged from care in a real-world clinical practice in the UK
    Alfaqawi, Fadi
    Elsherbiny, Samer
    Mushtaq, Bushra
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [30] Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson L.
    Aydogmus, Fatma Sema Akkan
    Lasalle, Claudia C.
    Ramsey, David J.
    LIFE-BASEL, 2023, 13 (02):
12345